Testing effectiveness (Phase 2)Ended earlyNCT01190111What this trial is testingStudy on Interleukin-7 (CYT107) in HIV PatientsWho this might be right forHIV Cytheris SA 23
Testing effectiveness (Phase 2)Looking for participantsNCT05639972What this trial is testingE7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersWho this might be right forHPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more Christian Hinrichs 15
Early research (Phase 1)Ended earlyNCT01088763What this trial is testingGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more National Cancer Institute (NCI) 129
Early research (Phase 1)Study completedNCT04773951What this trial is testingA Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid TumorsWho this might be right forMelanomaRenal CarcinomaUrothelial Carcinoma Shanghai Junshi Bioscience Co., Ltd. 47
Large-scale testing (Phase 3)UnknownNCT01809392What this trial is testingDecitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeWho this might be right forAcute Myelocytic LeukemiaMyelodysplastic Syndromes The First Affiliated Hospital of Soochow University 15
Not applicableEnded earlyNCT03293667What this trial is testingCharacterization of Regulatory T Lymphocytes in the Synovial Fluid of Patients Affected by Rheumatoid Arthritis.Who this might be right forRheumatoid ArthritisSwelling JointJoint Fluid+1 more University Hospital, Montpellier 19
Testing effectiveness (Phase 2)Study completedNCT03239392What this trial is testingA Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCLWho this might be right forLGL LeukemiaCTCL Bioniz Therapeutics 50
Testing effectiveness (Phase 2)WithdrawnNCT01101412What this trial is testingAntimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWho this might be right forChronic Myeloproliferative DisordersInfectionLeukemia+6 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00053131What this trial is testingCombination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Roswell Park Cancer Institute
Large-scale testing (Phase 3)Study completedNCT02304354What this trial is testingRelationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)Who this might be right forRheumatoid Arthritis University Hospital, Tours 70
Testing effectiveness (Phase 2)Looking for participantsNCT07473154What this trial is testingControlling Hyperactive Immunity With Long-lived LymphocytesWho this might be right forDiffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more Quell Therapeutics Limited 16
Early research (Phase 1)UnknownNCT00324597What this trial is testingAMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+1 more Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)Looking for participantsNCT06176690What this trial is testingConstitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive LymphomasWho this might be right forCD30-Positive Diffuse Large B-Cell LymphomaAnaplastic Large Cell Lymphoma, T Cell and Null Cell TypeAnaplastic Large Cell Lymphoma, ALK-Positive+4 more Baylor College of Medicine 90
Not applicableStudy completedNCT03549546What this trial is testingExpression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.Who this might be right forLung CancerSurgery Centre Hospitalier Universitaire de Saint Etienne 31
Not applicableStudy completedNCT03886350What this trial is testingImplication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk)Who this might be right forCystic FibrosisInnate ImmunityInflammatory Response University Hospital, Tours 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT01318317What this trial is testingGenetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin LymphomaWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+2 more City of Hope Medical Center 8
Testing effectiveness (Phase 2)UnknownNCT05915481What this trial is testingStereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid TumorsWho this might be right forAdvanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more Peking University Third Hospital 60
Not applicableUnknownNCT02721719What this trial is testingThe Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative ColitisWho this might be right forUlcerative Colitis University of British Columbia 50
Post-approval studies (Phase 4)Study completedNCT01656200What this trial is testingA Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2Who this might be right forJapanese EncephalitisJapanese Encephalitis Vaccine Indian Institute of Science 17
Testing effectiveness (Phase 2)Ended earlyNCT02327221What this trial is testingStudy Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's DiseaseWho this might be right forCrohn Disease TxCell 32